FFCP PHASE1:Mm9::chr19:41822065..41822074,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=31|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr19:41822065..41822074,-|id=chr19:41822065..41822074,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0005631!5.28e-16!3;UBERON:0000478!5.28e-16!3;UBERON:0000158!5.28e-16!3;UBERON:0000305!1.55e-12!1;UBERON:0001723!2.01e-12!1;UBERON:0001033!2.01e-12!1;UBERON:0010056!2.01e-12!1;UBERON:0006834!3.34e-12!1;UBERON:0005795!4.32e-12!4;UBERON:0000995!4.32e-12!4;UBERON:0003975!7.27e-10!5;UBERON:0001987!5.87e-07!2;UBERON:0003124!5.87e-07!2;UBERON:0004340!5.87e-07!2;UBERON:0000078!7.59e-07!2;UBERON:0000165!7.59e-07!2;UBERON:0000166!7.59e-07!2;UBERON:0000930!7.59e-07!2|ontology_enrichment_uberon_v019_2=UBERON:0005631,3.28e-58,3;UBERON:0000478,3.28e-58,3;UBERON:0000158,3.28e-58,3;UBERON:0000305,7.47e-44,1;UBERON:0001987,5.75e-23,2;UBERON:0003124,5.75e-23,2;UBERON:0004340,5.75e-23,2;UBERON:0004871,1.12e-15,3;UBERON:0005795,3.12e-12,4;UBERON:0000995,3.12e-12,4;UBERON:0003975,4.56e-10,5;UBERON:0004923,1.75e-08,24;UBERON:0003134,8.61e-07,8|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173485326766136,0,0,0,0,0,2.96633961281249,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.8874053147865,0,0.16488625294148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.218362563746178,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.453460767230423,0,0,0,0,0.187682475451182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0640251524048693,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr19:41822065..41822074,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=31 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr19:41822065..41822074,- | |||
|description=CAGE_peak_at_chr19:41822065..41822074,- | |||
|id=chr19:41822065..41822074,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0005631!5.28e-16!3;UBERON:0000478!5.28e-16!3;UBERON:0000158!5.28e-16!3;UBERON:0000305!1.55e-12!1;UBERON:0001723!2.01e-12!1;UBERON:0001033!2.01e-12!1;UBERON:0010056!2.01e-12!1;UBERON:0006834!3.34e-12!1;UBERON:0005795!4.32e-12!4;UBERON:0000995!4.32e-12!4;UBERON:0003975!7.27e-10!5;UBERON:0001987!5.87e-07!2;UBERON:0003124!5.87e-07!2;UBERON:0004340!5.87e-07!2;UBERON:0000078!7.59e-07!2;UBERON:0000165!7.59e-07!2;UBERON:0000166!7.59e-07!2;UBERON:0000930!7.59e-07!2 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0005631,3.28e-58,3;UBERON:0000478,3.28e-58,3;UBERON:0000158,3.28e-58,3;UBERON:0000305,7.47e-44,1;UBERON:0001987,5.75e-23,2;UBERON:0003124,5.75e-23,2;UBERON:0004340,5.75e-23,2;UBERON:0004871,1.12e-15,3;UBERON:0005795,3.12e-12,4;UBERON:0000995,3.12e-12,4;UBERON:0003975,4.56e-10,5;UBERON:0004923,1.75e-08,24;UBERON:0003134,8.61e-07,8 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173485326766136,0,0,0,0,0,2.96633961281249,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.8874053147865,0,0.16488625294148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.218362563746178,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.453460767230423,0,0,0,0,0.187682475451182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0640251524048693,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr19:41822065..41822074,- | |||
}} |
Latest revision as of 02:35, 4 August 2015
Short description: | p@chr19:41822065..41822074, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr19:41822065..41822074, - |
Coexpression cluster: | MCL_coexpression_mm9:31 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
extraembryonic membrane | 3.28e-58 | 3 |
extraembryonic structure | 3.28e-58 | 3 |
membranous layer | 3.28e-58 | 3 |
amnion | 7.47e-44 | 1 |
placenta | 5.75e-23 | 2 |
chorion | 5.75e-23 | 2 |
allantois | 5.75e-23 | 2 |
somatic layer of lateral plate mesoderm | 1.12e-15 | 3 |
embryonic uterus | 3.12e-12 | 4 |
uterus | 3.12e-12 | 4 |
internal female genitalia | 4.56e-10 | 5 |
organ component layer | 1.75e-08 | 24 |
female reproductive organ | 8.61e-07 | 8 |